AEON Biopharma: Funding, Investors & Team (Oct 2026)
AEON Biopharma is a biopharmaceutical company focused on the development of ABP-450, a proprietary 900 kDabotulinum toxin complex, for debilitating medical conditions. The company is dedicated to developing novel and proprietary treatment paradigms in order to improve patient outcomes and drive increased value for patients, physicians, and payers.
AEON Biopharma has raised $30.0M across 1 funding round on record, the most recent a Convertible Note of $30.0M announced in Aug 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AEON Biopharma Company Profile and Key Stats
Latest funding round on record: Aug 2022.
AEON Biopharma Funding Rounds
AEON Biopharma Founders and Leadership Team
Contact details for the AEON Biopharma team: 1 of 1 has an email address on file.
Start 14-day free trial →AEON Biopharma Funding Compared to Other Biotechnology Startups
AEON Biopharma's latest round of $30.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AEON Biopharma in Biotechnology and Newport Beach
Companies Similar to AEON Biopharma
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
AEON Biopharma Funding FAQs
What does AEON Biopharma do?
AEON Biopharma is a biopharmaceutical company focused on the development of ABP-450, a proprietary 900 kDabotulinum toxin complex, for debilitating medical conditions. The company is dedicated to developing novel and proprietary treatment paradigms in order to improve patient outcomes and drive increased value for patients, physicians, and payers.
How much funding has AEON Biopharma raised?
AEON Biopharma has raised $30.0M across 1 round on record. The most recent is a Convertible Note of $30.0M announced in Aug 2022.
When did AEON Biopharma last raise funding?
AEON Biopharma's most recent funding round on record is a Convertible Note of $30.0M, announced in Aug 2022.
Who is the CEO of AEON Biopharma?
Marc Forth is listed as CEO at AEON Biopharma.
Where is AEON Biopharma headquartered?
AEON Biopharma is based in Newport Beach, California, United States.
How many employees does AEON Biopharma have?
AEON Biopharma is in the 1-10 employee band.
How does AEON Biopharma's funding compare to other Biotechnology startups?
AEON Biopharma's latest round of $30.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's AEON Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AEON Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.